From a medical mistake to a clinical warning: The case of HBV mutant virus reactivation in haematological patients

British Journal of Haematology

Volumn 144, Issue 6, 2009, Pages 969-970

  Gabriele, Zoppoli ^a   Bianca, Bruzzone ^b   Patrizia, Caligiuri ^b   Antonino, Picciotto ^a   Enrico, Balleari ^a   Andrea, Bruzzone ^a   Giancarlo, Icardi ^a   Riccardo, Ghio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Hepatitis; Hepatitis B virus; Mutant; Non Hodgkin lymphoma; Prophylaxis; Reactivation

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; PREDNISONE; RITUXIMAB; VINBLASTINE; VINCRISTINE;

CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SCREENING; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LARGE CELL LYMPHOMA; LETTER; PRIORITY JOURNAL; VACCINATION; VIRUS LOAD; VIRUS MUTANT; VIRUS REACTIVATION;

AGED; ANTINEOPLASTIC AGENTS; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; VIRUS ACTIVATION;

EID: 60649087211     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07539.x     Document Type: Letter

References (10)

1. Coleman, P.F., Chen, Y.C. Mushahwar, I.K. (1999) Immunoassay detection of hepatitis B surface antigen mutants. Journal of Medical Virology, 59, 19 24.
2. Echevarria, J.M. Avellon, A. (2006) Hepatitis B virus genetic diversity. Journal of Medical Virology, 78 (Suppl. 1 S36 S42.
3. Hunt, C.M., McGill, J.M., Allen, M.I. Condreay, L.D. (2000) Clinical relevance of hepatitis B viral mutations. Hepatology, 31, 1037 1044.
4. Ijaz, S., Torre, F., Tedder, R.S., Williams, R. Naoumov, N.V. (2001) Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. Journal of Medical Virology, 63, 210 216.
5. Jongerius, J.M., Wester, M., Cuypers, H.T., van Oostendorp, W.R., Lelie, P.N., van der Poel, C.L. van Leeuwen, E.F. (1998) New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays. Transfusion, 38, 56 59.
6. Lalazar, G., Rund, D. Shouval, D. (2007) Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies. British Journal of Haematology, 136, 699 712.
7. Locarnini, S.A. (1998) Hepatitis B virus surface antigen and polymerase gene variants: potential virological and clinical significance. Hepatology, 27, 294 297.
8. Marzano, A., Angelucci, E., Andreone, P., Brunetto, M., Bruno, R., Burra, P., Caraceni, P., Daniele, B., Di Marco, V., Fabrizi, F., Fagiuoli, S., Grossi, P., Lampertico, P., Meliconi, R., Mangia, A., Puoti, M., Raimondo, G. Smedile, A. (2007) Prophylaxis and treatment of hepatitis B in immunocompromised patients. Digestive and Liver Disease, 39, 397 408.
9. Moerman, B., Moons, V., Sommer, H., Schmitt, Y. Stetter, M. (2004) Evaluation of sensitivity for wild type and mutant forms of hepatitis B surface antigen by four commercial HBsAg assays. Clinical Laboratory, 50, 159 162.
10. Roque-Afonso, A.M., Ferey, M.P., Ly, T.D., Graube, A., Costa-Faria, L., Samuel, D. Dussaix, E. (2007) Viral and clinical factors associated with surface gene variants among hepatitis B virus carriers. Antiviral Therapy, 12, 1255 1263.